These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 28423653

  • 21. Upgrading the Repertoire of miRNAs in Gastric Adenocarcinoma to Provide a New Resource for Biomarker Discovery.
    Pewarchuk ME, Barros-Filho MC, Minatel BC, Cohn DE, Guisier F, Sage AP, Marshall EA, Stewart GL, Rock LD, Garnis C, Lam WL.
    Int J Mol Sci; 2019 Nov 14; 20(22):. PubMed ID: 31739401
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.
    Shi H, Chen J, Li Y, Li G, Zhong R, Du D, Meng R, Kong W, Lu M.
    Oncotarget; 2016 Apr 19; 7(16):21579-90. PubMed ID: 26933913
    [Abstract] [Full Text] [Related]

  • 24. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M, Kong X, Wang H, Huang G, Ye C, He Z.
    Oncotarget; 2017 Jan 31; 8(5):8775-8784. PubMed ID: 28060739
    [Abstract] [Full Text] [Related]

  • 25. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
    Zhou H, Tang K, Xiao H, Zeng J, Guan W, Guo X, Xu H, Ye Z.
    J Exp Clin Cancer Res; 2015 May 21; 34(1):53. PubMed ID: 25991007
    [Abstract] [Full Text] [Related]

  • 26. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
    Kleivi Sahlberg K, Bottai G, Naume B, Burwinkel B, Calin GA, Børresen-Dale AL, Santarpia L.
    Clin Cancer Res; 2015 Mar 01; 21(5):1207-14. PubMed ID: 25547678
    [Abstract] [Full Text] [Related]

  • 27. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
    Shi Y, Chen Z, Gao J, Wu S, Gao H, Feng G.
    Oncol Rep; 2018 Oct 01; 40(4):2014-2022. PubMed ID: 30106437
    [Abstract] [Full Text] [Related]

  • 28. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
    Xiong J, Xiong K, Bing Z.
    Cancer Biomark; 2018 Feb 14; 21(3):535-546. PubMed ID: 29226853
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
    Wu YS, Lin H, Chen D, Yi Z, Zeng B, Jiang Y, Ren G.
    Gene; 2019 May 20; 697():86-93. PubMed ID: 30779946
    [Abstract] [Full Text] [Related]

  • 31. Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma.
    Yu J, Zhu M, Lv M, Wu X, Zhang X, Zhang Y, Li J, Zhang Q.
    Sci Rep; 2019 Dec 27; 9(1):19847. PubMed ID: 31882677
    [Abstract] [Full Text] [Related]

  • 32. Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis.
    Zhang MY, Li SH, Huang GL, Lin GH, Shuang ZY, Lao XM, Xu L, Lin XJ, Wang HY, Li SP.
    BMC Cancer; 2015 Feb 18; 15():64. PubMed ID: 25880914
    [Abstract] [Full Text] [Related]

  • 33. Prognostic values of GPNMB identified by mining TCGA database and STAD microenvironment.
    Yao K, Wei L, Zhang J, Wang C, Wang C, Qin C, Li S.
    Aging (Albany NY); 2020 Aug 21; 12(16):16238-16254. PubMed ID: 32833670
    [Abstract] [Full Text] [Related]

  • 34. A six-microRNA signature to predict outcomes of patients with gastric cancer.
    Chen J, Hu B, Wang W, Qian XJ, Shan BJ, He YF.
    FEBS Open Bio; 2019 Mar 21; 9(3):538-547. PubMed ID: 30868062
    [Abstract] [Full Text] [Related]

  • 35. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
    Nie K, Deng Z, Zheng Z, Wen Y, Pan J, Jiang X, Yan Y, Liu P, Liu F, Li P.
    DNA Cell Biol; 2020 Sep 21; 39(9):1532-1544. PubMed ID: 32644844
    [Abstract] [Full Text] [Related]

  • 36. A five-miRNA signature predicts survival in gastric cancer using bioinformatics analysis.
    Zhang Z, Dong Y, Hua J, Xue H, Hu J, Jiang T, Shi L, Du J.
    Gene; 2019 May 30; 699():125-134. PubMed ID: 30849543
    [Abstract] [Full Text] [Related]

  • 37. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
    Gu J, Li Y, Fan L, Zhao Q, Tan B, Hua K, Wu G.
    Oncotarget; 2017 Jul 25; 8(30):49201-49216. PubMed ID: 28484081
    [Abstract] [Full Text] [Related]

  • 38. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma.
    Dou D, Yang S, Lin Y, Zhang J.
    Cancer Biomark; 2018 Jul 25; 23(1):79-93. PubMed ID: 29991127
    [Abstract] [Full Text] [Related]

  • 39. Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
    Wang X, Yin Z, Zhao Y, He M, Dong C, Zhong M.
    Mol Med Rep; 2020 Mar 25; 21(3):1647-1657. PubMed ID: 32016476
    [Abstract] [Full Text] [Related]

  • 40. Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer.
    Yang Y, Qu A, Wu Q, Zhang X, Wang L, Li C, Dong Z, Du L, Wang C.
    Aging (Albany NY); 2020 Jan 11; 12(1):35-52. PubMed ID: 31926112
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.